» Articles » PMID: 32499756

The Immune Landscape of Visceral Adipose Tissue During Obesity and Aging

Overview
Specialty Endocrinology
Date 2020 Jun 6
PMID 32499756
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity and aging represent major health burdens to the global adult population. Both conditions promote the development of associated metabolic diseases such as insulin resistance. The visceral adipose tissue (VAT) is a site that becomes dysfunctional during obesity and aging, and plays a significant role during their pathophysiology. The changes in obese and aging VAT are now recognized to be partly driven by a chronic local inflammatory state, characterized by immune cells that typically adopt an inflammatory phenotype during metabolic disease. Here, we summarize the current knowledge on the immune cell landscape of the VAT during lean, obese, and aged conditions, highlighting their similarities and differences. We also briefly discuss possible linked mechanisms that fuel obesity- and age-associated VAT dysfunction.

Citing Articles

The association of visceral and subcutaneous fat areas with phenotypic age in non-elderly adults, mediated by HOMA-IR and HDL-C.

Liu Y, Xu M, Wang L, Meng L, Li M, Mu S Lipids Health Dis. 2025; 24(1):22.

PMID: 39856735 PMC: 11761183. DOI: 10.1186/s12944-025-02446-4.


Substrate stiffness dictates unique doxorubicin-induced senescence-associated secretory phenotypes and transcriptomic signatures in human pulmonary fibroblasts.

Du H, Rose J, Bons J, Guo L, Valentino T, Wu F Geroscience. 2025; .

PMID: 39826027 DOI: 10.1007/s11357-025-01507-x.


Regulation of Age-Related Lipid Metabolism in Ovarian Cancer.

Feng J, Rouse C, Taylor L, Garcia S, Nguyen E, Coogan I Int J Mol Sci. 2025; 26(1.

PMID: 39796176 PMC: 11720209. DOI: 10.3390/ijms26010320.


Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions.

Wang T, Zhou D, Hong Z MedComm (2020). 2025; 6(1):e70030.

PMID: 39764565 PMC: 11702502. DOI: 10.1002/mco2.70030.


Gut Microbiota-microRNA Interactions and Obesity Pathophysiology: A Systematic Review of Integrated Studies.

Azari H, George M, Albracht-Schulte K Int J Mol Sci. 2024; 25(23).

PMID: 39684547 PMC: 11640985. DOI: 10.3390/ijms252312836.


References
1.
Defuria J, Belkina A, Jagannathan-Bogdan M, Snyder-Cappione J, Carr J, Nersesova Y . B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci U S A. 2013; 110(13):5133-8. PMC: 3612635. DOI: 10.1073/pnas.1215840110. View

2.
Amano S, Cohen J, Vangala P, Tencerova M, Nicoloro S, Yawe J . Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. Cell Metab. 2013; 19(1):162-171. PMC: 3931314. DOI: 10.1016/j.cmet.2013.11.017. View

3.
Kennedy D, Knight K . Inhibition of B Lymphopoiesis by Adipocytes and IL-1-Producing Myeloid-Derived Suppressor Cells. J Immunol. 2015; 195(6):2666-74. PMC: 4561202. DOI: 10.4049/jimmunol.1500957. View

4.
OSullivan T, Rapp M, Fan X, Weizman O, Bhardwaj P, Adams N . Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance. Immunity. 2016; 45(2):428-41. PMC: 5004886. DOI: 10.1016/j.immuni.2016.06.016. View

5.
Mahlakoiv T, Flamar A, Johnston L, Moriyama S, Putzel G, Bryce P . Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33. Sci Immunol. 2019; 4(35). PMC: 6766755. DOI: 10.1126/sciimmunol.aax0416. View